CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow [4]

Blood

Volumn 103, Issue 5, 2004, Pages 1968-1969

  Jaksic, Ozren ^b   Kardum Paro, Mirjana Mariana ^b   Kardum Skelin, Ika ^b   Kusec, Rajko ^b   Pejsa, Vlatko ^b   Jaksic, Branimir ^a  

^a University of Zagreb   (Croatia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD31 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY;

ADULT; AGED; B LYMPHOCYTE; BLOOD; BONE MARROW; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL; LYMPH NODE; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL;

EID: 1442331700     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-10-3612     Document Type: Letter

References (8)

1. Deaglio S, Capobianco A, Bergui L, et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood. 2003;102:2146-2155.
2. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
3. Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99:1023-1029.
4. D'Arena G, Nunziata G, Coppola G, et al. CD38 expression does not change in B-cell chronic lymphocytic leukemia. Blood. 2002;100:3052-3053.
5. Ghia P, Guida G, Stella S, et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood. 2003;101:1262-1269.
6. Jaksic O, Vrhovac R, Kusec R, et al. Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia. Haematologica. 2001;86:827-836.
7. Jaksic B, Vitale B. Total tumour mass score (TTM): a new parameter in chronic lymphocyte leukaemia. Br J Haematol. 1981;49:405-413.
8. Morabito F, Mangiola M, Stelitano C, et al. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Haematologica. 2003;88:354-355.